Browsing by Author MORGENSTERN Alfred

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 80 to 99 of 115 < previous   next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2009JRC53299Radioimmunotherapy of Breast Cancer Metastases with Alpha-Particle-emitter 225Ac: Comparing Efficacy with 213Bi, 90YSONG Hong; HOBBS Robert F.; VAJRAVELU Ravy; HUSO David L.; ESAIAS Caroline; APOSTOLIDIS Christos; MORGENSTERN Alfred; SGOUROS GeorgeArticles in Journals
2013JRC80499Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian CellsBRYAN R. A.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.Articles in Journals
2009JRC55683Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2012JRC75576Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histonesDADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN AContributions to Conferences
2009JRC54481Radiolabeled Antibodies to Bacillus Anthracis Toxins are Bactericidal and Partially Therapeutic in Experimental Murine AnthraxRIVERA J.; NAKOUZI A.s.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DADACHOVA E.Articles in Journals
2012JRC70296Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.Contributions to Conferences
2013JRC82797Retention studies in polymer vesicles of recoiling atoms as a result of alpha decayWANG G.; VAN BUEREN J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; WOLTERBEEK H.th.; MENDES E; DENKOVA A.g.Contributions to Conferences
2014JRC80502Retention studies of recoiling daughter nuclides of 225Ac in polymer vesiclesWANG G.; DE KRUIJFF R. M.; ROL A; THIJSSEN L.; MENDES E; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; STUART M.c.a.; WOLTERBEEK H.th.; DENKOVA A.g.Articles in Journals
2010JRC61749Sequential Cytarabine and a-Particle Immunotherapy with Bismuth-213¿Lintuzumab (HuM195) for Acute Myeloid LeukemiaROSENBLAT Todd; MCDEVITT Michael; MULFORD D.a.; PANDIT-TASKAR N.; DIVGI C.r.; PANAGEAS Katherine; HEANEY M. L.; CHANEL S.; MORGENSTERN Alfred; SGOUROS George, et alArticles in Journals
2011JRC59480Simultaneous Experimental Determination of Energy and Intensity of Cyclotron Beams in the Energy Range Below 40 MeVABBAS Kamel; SIMONELLI Federica; HOLZWARTH Uwe; CYDZIK Izabela; BULGHERONI ANTONIO; GIBSON Peter; KOZEMPEL JAN; MORGENSTERN AlfredArticles in Journals
2009JRC54280Spectroscopic Study of the Interaction of U(VI) with Transferrin and Albumin for Speciation of U(VI) under Blood Serum ConditionsMONTAVON Gilles; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; REPINC Urska; MORGENSTERN AlfredArticles in Journals
2014JRC88672Step forward with Bi-213: Cyclen-based phosphonates show improved radiolabeling and stabilityŠIMEČEK Jakub; HERMANN Petr; SEIDL C.; MORGENSTERN Alfred; NOTNI Johannes; BRUCHERTSEIFER Frank; WESTER Hans-JürgenContributions to Conferences
2013JRC84755Substance P - nanozeolite labeled with 224Ra and 225Ra - new potential radiobioconjugate for internal alpha therapyLESZCZUK Edyta; PIOTROWSKA A; KOŹMIŃSKI P; BILEWICZ Aleksander; MORGENSTERN Alfred; BRUCHERTSEIFER FrankContributions to Conferences
2012JRC71710Synthesis and in vitro evaluation of 225Ac-DOTA-SubstanceP for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA AGNIESZKA; BRUCHERTSEIFER Frank; WEIS Mirjam; BONELLI Milton; LAURENZA M; APOSTOLIDIS Christos; MORGENSTERN AlfredContributions to Conferences
2013JRC80486Synthesis of 213Bi-DOTATOC for peptide receptor a-therapy of GEP-NET patients refractory to β-therapyBRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2012JRC72901Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapyMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2010JRC53275Synthesis of Bimetallic Uranium and Neptunium Complexes of a Binucleating Macrocycle and Determination of the Solid-State Structure by Magnetic AnalysisARNOLD Polly L.; POTTER Natalie A.; MAGNANI Nicola; APOSTOLIDIS Christos; GRIVEAU Jean-Christophe; COLINEAU Eric; MORGENSTERN Alfred; CACIUFFO Roberto; LOVE Jason B.Articles in Journals
2013JRC81654Targeted alpha therapy of glioblastoma multiforme with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOCIARA Henryk; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2014JRC88673Targeted alpha therapy of glioblastoma multiforme: First clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2013JRC82711Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences